ADVANCED PROTEOME THERAPEUTICS CORPORATION
Profil

Our technology is based on a proprietary protein modification platform that can be used to attach entities to therapeutic proteins to enhance their properties and/or endow them with additional functions. Overall, our proprietary technology is based on "The Foundation Trinity™", which utilizes targeted therapy, combination therapy, and immunotherapy, in a single agent of high purity. Advanced, targeted therapies such as ours are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future.
Quelle: Unternehmen (http://www.advancedproteome.com )
Land | Website | Branche |
---|---|---|
|
www.advancedproteome.com |
|
Aktien | |||
---|---|---|---|
|